Index I-39
n Prediabetes, 299
Predictions, scientific, 6–7, 7f
Prefrontal cortex, 254f, 255, 257, 257f
Preganglionic neurons, 250
Pregnancy. See also Development;
Prenatal development
n assisted reproductive technology
and, 305, 318–319, 318f, 319f
and cardiovascular system, 131
n diet in, 344–345
drug use in, 345
n ectopic, 333, 352, 352f
n herpes infection and, 280
n HIV transmission in, 172
n home tests for, 169, 169f, 223, 333
n medical advice in, 352
n miscarriage, 344, 345, 350, 361
n Rh blood typing and, 148, 148f
sexual intercourse and, 314
and smoking, 188f
n STDs and, 321
n toxoplasmosis and, 350
weight gain in, 345
Prehensile hand movements,
450–451, 451f
n Preimplantation diagnosis, 346
n Premature birth, 37, 184, 340,
342–343, 345
n Premenstrual syndrome (PMS), 328
Premolars, 198, 198f
Premotor cortex, 254
Prenatal development. See also Birth;
Embryo(s); Fetus; Pregnancy
comparative, as evidence for
evolution, 446–447, 447f
n disorders of, 344–345, 344f, 345f
embryo implantation, 332–333,
332f, 333f
embryonic period, 330–339,
330f–339f, 330t
endocrine system role in, 347
extraembryonic membrane
formation in, 336, 336f, 337f
fetal period, 340–341, 340f, 341f
overview of, 330–331, 330f, 330t, 331f
retina formation in, 279
sex chromosomes and, 388, 388f
stages of, 347, 347t
Pressure
atmospheric, 180, 180f
blood. See Blood pressure
intrapulmonary, 182
sensory system response to, 131, 268
Pressure gradients, in respiration,
180–181, 180f, 182, 184–185, 185f
Presynaptic cells, 244
Primary consumers, 462, 463f, 464f
Primary immune response, 162, 162f
Primary motor cortex, 254, 254f, 255f
Primary oocytes, 308, 308f, 362–363,
363f, 370
Primary productivity, 464, 464f
Primary somatosensory cortex, 254f,
- See also Somatosensory
cortex
Primary spermatocytes, 312, 312f,
362, 363f
Primary structure of protein, 33, 33f,
34, 34f
Primary succession, 460, 461f
Primary tissues (germ layers), 330,
330t, 331f, 334
Primary visual cortex, 254f, 255. See
also Visual cortex
Primates
classification of, 3
evolution of, 447, 447f, 448, 450–451,
450f, 452–453
n Primers (in PCR), 415, 415f
Primitive streak, 334, 334f
Primordial Earth, 454, 454f
n Principle of sustainability,
486–487, 489
Probability (in genetics). See also
Punnett square
n calculation of, 376–377, 376f, 377f
factors affecting, 380–381, 380f, 381f
in genetic analysis, 390, 391
independent assortment and,
376–377, 377f, 386
Probiotic bacteria, 208
Problem identification, in scientific
method, 6
Processes
of bone cell, 88
of neuron, 73
n Producers (autotrophs), 4, 5f,
462, 462f, 463f, 464, 464f,
468, 468f, 478
Product (of metabolic reaction), 59
n Progeria, 401t, 406
Progestational phase, of menstrual
cycle, 307, 309t
Progesterone, 287f, 288t, 292t, 296, 300,
306–307, 308–309, 309f, 333, 336,
343, 349
n Progestin injections/implants,
316t, 317
Prokaryotic cells, 42, 42f, 42t
Prolactin, 286, 287f, 288t, 290t,
291, 291f
Proliferating phase, of menstrual cycle,
307, 309t
Proline, 410f, 411
Prometaphase, 358
Prometea (cloned horse), 421f
Promoter (in transcription), 408,
408f–409f
Pronation, 97f
Proofreading of DNA, 407
Prophase (mitosis), 356f, 358, 359f,
368f–369f
Prophase I (meiosis), 362, 363, 364,
364f–365f, 366, 368f–369f, 370
Prophase II (meiosis), 362, 364f–365f,
365, 368f–369f
Prostaglandins, 161, 170, 268, 286, 286t,
311, 342
n Prostate, enlarged, 325
n Prostate cancer, 17, 37, 169, 325, 325f,
431f, 432, 432t
Prostate gland, 310f, 310t, 311,
312f, 314
Prostate-specific antigen (PSA), 432
blood test for, 325
Protease inhibitors, 172
Protection, as bone function, 90, 90t
Protein(s), 32–33, 39t. See also Enzymes
adhesion, 335
amino acids in, 32–33, 32f, 33f, 34,
410, 410f, 411, 411f, 412, 412f,
448, 448f
n amyloid, 258
animal, 213
as antigens, 156
ATP production using, 59
as biological molecule, 26
in blood, and immune response, 161
in blood clotting, 394–395
in bone formation, 88
in cell junctions, 74
channel, 240, 241f, 242–243,
242f–243f
in chromosomes, 354, 354f
complement, 160–161, 161f, 164, 165,
165t, 171
connective tissue secretion of, 70
contractile, 360
C-reactive, 135, 135t
defense, 32t
denaturation of, 35, 35f
digestion of, 196f, 200, 202, 204, 205f,
205t, 225, 233
as energy source, 63
fibrous, 34
functional groups in, 26, 26f
globular, 34
glycoproteins, 34
HER2, 169
lipoproteins, 34–35, 142 (See also
HDLs; LDLs)
metabolism of, 63
movement of, 32t
in muscle cells, 108, 108f, 110, 111f
in nuclear envelope, 48, 49f
n nutritional recommendations on,
213, 213f
pH effect on, 24
plant, 213
plasma, 142, 142f, 161
in plasma membranes, 46, 46f, 48, 49f
primordial origin of, 455, 455f
receptor, 32t, 46, 46f, 48, 244, 244f
recognition, 46, 46f
regulatory, 32, 32t, 409, 428
REST, 352
Copyright 2016 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).